Analystreport

Collegium Pharmaceutical Inc (NASDAQ: COLL) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $36.00 price target on the stock.

Collegium Pharmaceutical, Inc.  (COLL) 
Last collegium pharmaceutical, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.collegiumpharma.com